Temafloxacin (marketed by Abbott Laboratories as Omniflox) is a fluoroquinolone antibiotic drug which was withdrawn from sale in the United States shortly after its approval in 1992 because of serious adverse effects resulting in three deaths.
Temafloxacin, sold under the brand name Omniflox by Abbott Laboratories, is a fluoroquinolone antibiotic that was swiftly withdrawn from U.S. markets following its introduction in 1992 because it caused serious side effects resulting in three deaths.